InvestorsHub Logo

Anonymous Fish

11/21/19 10:11 AM

#229193 RE: KCSVEN #229176

Agreed. Thanks for the reply.

So do you think they will be able to sustain a market cap valuation of $8B in 2020 or do you see a big sell off?

It doesnt seem to me to be a good stock to sell/short because a concrete BO bid could be tabled at any time in 2020. Yes the valuation is currently excessive, but NOT if they receive a BO offer it isnt because an offer would be a multiple of the current market cap. Seems to me to be a hold and add on any weakness kind of a deal.

That BO offer 'threat' scenario really limits any significant downside IMO and any real future downside only comes if/when Amarin refuse any BO offers and make it very clear that they are going it alone.

KevGee59

11/21/19 11:00 AM

#229217 RE: KCSVEN #229176

I guess they will be lucky to hit 1 billion in 2020


I not one of the smartest posters here...and didn't need to say this for the MB to know.

But I would think...with expanded label it should be rather easy to double from around $500 mil this year...to $1bn next year.

Amarin has almost doubled sales the last two years 'without' expanded label. DTC advertising will matter...and make a difference. But the 1st half 2020 shouldn't drag with what is going to be on the expanded label. It will get prescribed...and insurers will cover...IMO.

In all reality...I wouldn't be surprised if they didn't do $1.2bn in 2020.

But like I said...not the brightest poster on the wall...

KG ;)